Asia Pacific Semi Solid Dosage Contract Manufacturing Market Size & Outlook
The semi solid dosage contract manufacturing market in Asia Pacific is expected to reach a projected revenue of US$ 12,073.0 million by 2030. A compound annual growth rate of 12% is expected of Asia Pacific semi solid dosage contract manufacturing market from 2025 to 2030.
Revenue, 2024 (US$M)
$6,155.0
Forecast, 2030 (US$M)
$12,073.0
CAGR, 2025 - 2030
12%
Report Coverage
Asia Pacific
Asia Pacific semi solid dosage contract manufacturing market, 2018-2030 (US$M)
Related Markets
Asia Pacific semi solid dosage contract manufacturing market highlights
- The Asia Pacific semi solid dosage contract manufacturing market generated a revenue of USD 6,155.0 million in 2024.
- The market is expected to grow at a CAGR of 12% from 2025 to 2030.
- In terms of segment, topical was the largest revenue generating type in 2024.
- Transdermal is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 6,155.0 million |
| Market revenue in 2030 | USD 12,073.0 million |
| Growth rate | 12% (CAGR from 2025 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Transdermal |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Transdermal, Oral |
| Key market players worldwide | Lonza Group Ltd, The Lubrizol Corp, Cambrex, Contract Pharmaceuticals Limited, Bora Pharmaceuticals, Ascendia Pharmaceuticals, Pierre Fabre, Piramal Pharma Solutions, DPT Laboratories, MedPharm, Catalent Inc, Recipharm, Almac Group, Ajinomoto Co Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 31.7% of the global semi solid dosage contract manufacturing market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 12,073.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Semi Solid Dosage Contract Manufacturing Market Scope
Semi solid dosage contract manufacturing market segmentation & scope
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Norway
Sweden
China
Japan
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Semi Solid Dosage Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific semi solid dosage contract manufacturing market size, by country, 2018-2030 (US$M)
Asia Pacific Semi Solid Dosage Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
